The current state of lung cancer treatment
Wednesday, December 12, 2012 - 13:00
in Health & Medicine
A new review outlines the current state of lung cancer treatment. It points out that in the lung cancer varieties whose driver oncogenes can be matched with targeted therapy, tend to give a 70-80 percent patient response as opposed to 20-30 percent response to traditional chemotherapies, and with much reduced side effects.